Study guide

34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

Key Takeaways Explain This Topic AI

The dentate (pectinate) line is the critical anatomical landmark: lesions above the dentate line (internal hemorrhoids) have visceral innervation from the inferior mesenteric plexus and are insensitive to sharp pain, whereas lesions below the line (external hemorrhoids, fissures, perianal abscesses) have somatic sensory innervation from the inferior rectal nerves (pudendal nerve branches) and cause intense, sharp pain.

Internal hemorrhoids are graded by Goligher Staging (Grade I: bleed, no prolapse; Grade II: spontaneous reduction; Grade III: manual reduction; Grade IV: irreducible). Rubber Band Ligation (RBL) is the most effective office-based procedure for symptomatic Grades I to III; surgical hemorrhoidectomy is reserved for Grade IV, strangulated, or medically refractory disease.

Acute thrombosed external hemorrhoids presenting within 72 hours of symptom onset should be treated with complete elliptical surgical excision under local anesthesia for rapid, definitive pain relief; presentations beyond 72 hours should receive conservative management (sitz baths, stool softeners, topical analgesics) as spontaneous thrombus reorganization is underway.

Anal fissures typically occur in the posterior midline (90%); lateral anal fissures are atypical and strongly indicate underlying systemic pathology (Crohn disease, HIV, tuberculosis, syphilis, or anal carcinoma). First-line medical therapy consists of topical vasodilators (0.2% nitroglycerin ointment or 0.2-0.3% diltiazem/nifedipine gel for 6-8 weeks) to relax the internal anal sphincter and restore microvascular perfusion.

Anorectal abscesses arise from infected anal crypt glands at the dentate line (cryptoglandular origin); acute perianal abscess requires prompt surgical incision and drainage without delay for imaging or antibiotics alone, and patients must be counseled that 30% to 50% will develop a persistent fistula-in-ano.

Last updated: September 2026

Anorectal Surgical Anatomy: The Dentate (Pectinate) Line

The dentate (pectinate) line is the single most critical anatomical landmark in anorectal medicine. Located approximately 2 cm proximal to the anal verge, it represents the embryologic transition zone between the endoderm-derived hindgut and the ectoderm-derived proctodeum. Differentiating whether a lesion is situated proximal or distal to this line dictates clinical symptoms, vascular drainage, lymphatic spread, and procedural tolerability.

Anatomic and Clinical Comparison Across the Dentate Line

  • Anatomic Feature Proximal (Above) Dentate Line Distal (Below) Dentate Line
  • Embryologic Origin Endoderm (Hindgut) Ectoderm (Proctodeum)

Epithelial Lining Columnar and transitional mucosa Non-keratinized stratified squamous epithelium ( anoderm ) transitioning to keratinized perianal skin

Sensory Innervation Visceral Autonomic (Inferior hypogastric / pelvic splanchnic nerves); • Insensitive to sharp cutting, burning, or pinprick ; • Sensitive only to stretch, tension, and distension Somatic Sensory (Inferior rectal nerves from the Pudendal Nerve , S2-S4); • Exquisitely sensitive to sharp cutting, tearing, temperature, and pinprick

Arterial Supply Superior rectal artery (from Inferior Mesenteric Artery) and Middle rectal artery (from Internal Iliac) Inferior rectal artery (from Internal Pudendal Artery)

Venous Drainage Superior rectal vein → Inferior mesenteric vein → Portal Venous System Inferior rectal vein → Internal pudendal vein → Internal iliac vein → Systemic Venous System (IVC)

Lymphatic Drainage Internal iliac and inferior mesenteric lymph nodes Superficial inguinal lymph nodes

Hallmark Pathology Internal Hemorrhoids (typically painless bright red bleeding, prolapse) External Hemorrhoids, Anal Fissures, Perianal Abscesses (exquisite, sharp, throbbing somatic pain)

Important

Procedural Significance of the Dentate Line :

Because the mucosa above the dentate line lacks somatic pain fibers, office-based interventions for internal hemorrhoids—such as Rubber Band Ligation (RBL) , sclerotherapy, and infrared coagulation—can be performed in the outpatient clinic without local anesthesia. However, if a rubber band or sclerosing needle is inadvertently placed distal to the dentate line onto the somatically innervated anoderm, it triggers immediate, excruciating, unbearable pain!

Internal Hemorrhoids: Goligher Staging & Treatment Hierarchy

Internal hemorrhoids are normal, physiologic, vascular-submucosal cushions composed of arteriovenous sinusoids, smooth muscle (Treitz's muscle), and elastic connective tissue. They are situated in three primary anatomical positions: left lateral (3 o'clock), right anterolateral (7 o'clock), and right posterolateral (11 o'clock) (referenced in the lithotomy position). Chronic straining, increased intra-abdominal pressure, pregnancy, aging, and chronic constipation cause fragmentation of the connective tissue framework, leading to vascular engorgement, venous dilation, and mucosal prolapse.

Clinical Presentation

Cardinal Symptom : Painless, intermittent, bright red blood per rectum (BRBPR) . Bleeding characteristically coats the external surface of the stool bolus, drips into the toilet bowl after defecation ("splashing"), or is visualized as bright red blood on the toilet paper.

Secondary Symptoms : Sensation of perianal fullness, incomplete evacuation, mucus discharge (from prolapsed columnar epithelium), and secondary pruritus ani.

Clinical Red Flag : Internal hemorrhoids do NOT cause pain unless they become acutely incarcerated, strangulated, and gangrenous (Grade IV), or if there is a coexisting acute anal fissure or perianal thrombosis!

Goligher Classification of Internal Hemorrhoids GOLIGHER INTERNAL HEMORRHOID STAGING

  • GRADE I ──> Prominent vascular cushions that bleed; NO prolapse outside anal canal
  • GRADE II ──> Prolapses through anal canal during defecation; REDUCES SPONTANEOUSLY
  • GRADE III ──> Prolapses through anal canal during defecation; REQUIRES MANUAL REDUCTION
  • GRADE IV ──> Permanently prolapsed; IRREDUCIBLE manually; risk of strangulation

Grade I : Prominent hemorrhoidal veins that bleed with defecation but do not prolapse below the dentate line or through the anal verge.

Grade II : Hemorrhoids prolapse past the anal verge during defecation or straining but reduce spontaneously upon cessation of straining.

Grade III : Hemorrhoids prolapse past the anal verge with defecation or minimal exertion and require manual reduction by the patient pushing them back into the anal canal.

Grade IV : Hemorrhoids are chronically, permanently prolapsed and cannot be manually reduced . The chronically exposed mucosa is prone to ulceration, thrombosis, vascular strangulation, and ischemic necrosis.

  • Stepwise Management Hierarchy
  • 1. Conservative First-Line Medical Management (All Grades)

Dietary Fiber Supplementation : 25 to 35 grams of soluble fiber daily (e.g., psyllium husk 3.4 to 10 g daily or methylcellulose) combined with generous water intake (≥1.5 to 2 liters daily) softens stool, expands bulk, and significantly reduces bleeding and prolapse episodes.

Defecation Behavior Modification : Strictly avoid straining; limit toilet sitting time to less than 3 to 5 minutes (prohibit reading or mobile phone use on the toilet); utilize a footstool to elevate the knees (squatting posture straightens the anorectal angle).

Sitz Baths : Warm water sitz baths (15 to 20 minutes two to three times daily, especially following bowel movements) relieve anal sphincter hypertonicity and promote microvascular blood flow.

Topical Formulations : Short-course topical hydrocortisone creams or suppositories relieve local inflammation and itching; use must be restricted to ≤7 consecutive days to avoid anoderm mucosal thinning, atrophy, and contact dermatitis.

2. Office-Based Procedures (Grades I, II, and Selected Grade III)

When conservative medical therapy fails to control bleeding or prolapse in Grade I to III internal hemorrhoids:

Rubber Band Ligation (RBL) : The most effective and durable office-based procedure with the lowest long-term recurrence rate. Using an anoscope and ligator, an elastic rubber band is placed around the redundant hemorrhoidal mucosa and vascular pedicle at least 1 cm above the dentate line . The band induces ischemic necrosis, causing the banded tissue to slough within 5 to 7 days, leaving a superficial ulcer that heals with mucosal cicatrization and fixation of the submucosa to the rectal wall.

Complications : Mild dull rectal ache (normal); delayed bleeding at days 7 to 14 when the necrotic eschar sloughs (caution in patients taking antiplatelet or anticoagulant agents).

Life-Threatening Red Flag: Perineal Pelvic Sepsis : The triad of severe escalating anal pain, high fever, and acute urinary retention following rubber band ligation indicates necrotizing pelvic soft-tissue infection (Fournier gangrene). Mandates emergent band removal, broad-spectrum IV antibiotics, and surgical debridement.

Infrared Photocoagulation (IRC) & Sclerotherapy : Direct application of infrared light energy or injection of 5% phenol in almond oil into the submucosal vascular pedicle causes protein coagulation and fibrosis. Effective for bleeding Grade I and II hemorrhoids; carries lower post-procedural discomfort than RBL but significantly higher 1-year recurrence rates.

3. Surgical Hemorrhoidectomy

Indications : Refractory Grade III hemorrhoids failing office procedures, all Grade IV internal hemorrhoids , acutely strangulated/gangrenous hemorrhoids, and combined severe internal and external hemorrhoidal disease.

Procedures : Excisonal hemorrhoidectomy (Ferguson closed hemorrhoidectomy or Milligan-Morgan open hemorrhoidectomy).

Postoperative Complications : Severe postoperative pain, urinary retention (15% to 30%), delayed hemorrhage, anal canal stenosis, and permanent minor fecal incontinence from accidental internal anal sphincter injury.

External Hemorrhoids & Acute Thrombosis: The 72-Hour Rule

External hemorrhoids originate from the inferior hemorrhoidal venous plexus distal to the dentate line and are covered by somatically innervated anoderm and perianal squamous epithelium. Uncomplicated external hemorrhoids manifest as soft perianal skin tags or folds that cause hygiene difficulty and mild itching.

Acute Thrombosed External Hemorrhoid

Pathophysiology : A sudden, transient surge in systemic venous pressure (e.g., heavy physical lifting, intense straining at stool, vigorous coughing paroxysm, or vaginal delivery) leads to microvascular rupture and clot formation within the subcutaneous external hemorrhoidal plexus.

Clinical Presentation : Sudden, explosive onset of intense, constant, severe, throbbing perianal pain that makes sitting, walking, or defecating virtually impossible.

Physical Examination : A tense, exquisitely tender, firm, non-compressible, smooth, bluish-purple subcutaneous nodule or mass located at the anal verge. ACUTE THROMBOSED EXTERNAL HEMORRHOID MANAGEMENT

  • Patient Presents with Painful Perianal Mass
  • │
  • ┌──────────────────────────┴──────────────────────────┐
  • ▼ ▼
  • ONSET <=72 HOURS ONSET >72 HOURS
  • │ │
  • Pain is intense/escalating Pain has peaked and is improving
  • │ │
  • ▼ ▼
  • COMPLETE SURGICAL EXCISION CONSERVATIVE MEDICAL THERAPY
  • Under local anesthesia (1% lidocaine) • Warm water sitz baths TID
  • Elliptical incision removes clot & skin • Stool softeners & high fiber
  • Definitive relief, low recurrence (<5%) • Topical 2% lidocaine jelly / analgesics
  • AVOID simple incision/drainage (high relapse) • Spontaneous thrombus resorption in 2-4 wks

Important

The 72-Hour Clinical Decision Rule for Thrombosed External Hemorrhoids :

Presentation ≤72 Hours from Symptom Onset : Complete elliptical surgical excision of the entire thrombosed hemorrhoidal complex under local anesthesia (1% or 2% lidocaine with epinephrine) provides rapid, definitive pain relief, prevents secondary bleeding, and carries an exceptionally low recurrence rate (<5%). Note: Simple incision and clot evacuation (I&D) is discouraged because it carries a 30% to 40% recurrence rate and persistent painful skin tags.

Presentation >72 Hours from Symptom Onset : Severe throbbing pain peaks within the first 48 to 72 hours and begins to diminish as the thrombus organizes, neovascularizes, and undergoes spontaneous resorption. Surgical excision after 72 hours offers minimal incremental pain relief and substitutes a surgical wound for an already resolving condition. Manage conservatively : warm sitz baths, oral NSAIDs or acetaminophen, stool softeners, high fiber, and topical 2% lidocaine jelly. Complete resorption occurs naturally over 2 to 4 weeks, occasionally leaving a painless skin tag.

Anal Fissure: Midline vs. Lateral & Acute vs. Chronic

An anal fissure is a painful longitudinal tear or ulceration in the anoderm extending from the dentate line to the anal verge.

Anatomic Localization: Benign Midline vs. Atypical Lateral

Posterior Midline (90% of Cases) : The overwhelming majority of primary anal fissures occur in the posterior midline. This predisposition is anatomical: the posterior commissure of the anal canal receives the poorest microvascular blood supply (a relative watershed zone) and possesses the least muscular support from the overlapping fibers of the external anal sphincter.

Anterior Midline (10% of Cases) : More common in women, frequently associated with anterior perineal trauma or attenuation during vaginal delivery.

Lateral or Off-Midline Anal Fissures (High-Yield Board Pearl!) :

Any anal fissure located away from the posterior or anterior midline (i.e., at the 3 o'clock, 9 o'clock, or lateral positions) or multiple fissures occurring simultaneously are ATYPICAL .

An atypical lateral fissure must never be dismissed as simple trauma; it strongly signals an underlying systemic disease:

  • Crohn Disease (most common systemic cause of complex/lateral fissures);
  • HIV / AIDS (including opportunistic ulcerations, CMV, or Kaposi sarcoma);
  • Syphilis (primary syphilitic chancre);
  • Tuberculosis (anal tuberculous ulcer);
  • Anal Squamous Cell Carcinoma ;

Leukemia or severe agranulocytosis.

Clinical Mandate : Lateral or painless fissures require formal diagnostic investigation: targeted serologies (HIV, syphilis), biopsy, and colonoscopy to rule out inflammatory bowel disease.

Acute vs. Chronic Anal Fissure

Pathophysiologic Vicious Cycle : A hard stool tears the anoderm → somatic pain triggers intense involuntary spasm and hypertonicity of the internal anal sphincter → elevated resting sphincter pressure severely compromises microvascular capillary perfusion to the posterior midline anoderm → persistent ischemia prevents epithelial wound healing → subsequent defecation causes recurrent tearing and sustained spasm.

Acute Fissure (<6 Weeks Duration) : Appears as a fresh, superficial, linear tear with clean, sharp edges, resembling a fresh paper cut.

Chronic Fissure (>6 Weeks Duration) : Characterized by a deep ulcer with exposed white, transverse circular fibers of the internal anal sphincter at its base, accompanied by the classic diagnostic triad of chronic fissure :

  • Hypertrophic Anal Papilla at the proximal edge (dentate line);
  • Chronic Fissure Ulcer Bed with visible transverse sphincter fibers;

Sentinel Skin Tag ("Sentinel Pile") at the distal anal verge.

Clinical Presentation

Cardinal Symptom : Exquisite, sharp, knife-like, tearing pain during defecation (classically described by patients as "passing shards of broken glass" ), followed by a persistent, dull, burning ache that lasts for 1 to 4 hours post-defecation due to sustained internal sphincter spasm.

Hematochezia : Bright red blood on the toilet paper upon wiping or a thin red streak along the surface of hard stool.

Stepwise Management Hierarchy ANAL FISSURE TREATMENT CASCADE

  • STEP 1: FIRST-LINE MEDICAL THERAPY (6 to 8 Weeks)
  • High-fiber diet (25-35 g/d) + Stool Softener (PEG 3350) + Warm Sitz Baths
  • TOPICAL VASODILATORS (Relaxes internal sphincter & restores microcirculation):
  • Topical 0.2% Nitroglycerin (Rectiv) ointment BID (Headache in 20-30%)
  • Topical 0.2% to 0.3% Diltiazem or Nifedipine gel BID (Equivalent efficacy, no headache)
  • STEP 2: SECOND-LINE CHEMICAL DENERVATION
  • Botulinum Toxin A Injection (20 to 50 Units into internal anal sphincter)
  • Inhibits acetylcholine release, producing temporary sphincter paralysis for 2-3 months
  • Healing rate ~60-80%; transient flatus incontinence in ~5%
  • STEP 3: THIRD-LINE SURGICAL GOLD STANDARD
  • Lateral Internal Sphincterotomy (LIS)
  • Partial division of internal sphincter up to dentate line
  • Healing rate >90-95%
  • Irreversible Risk: Permanent minor fecal or flatus incontinence in 5% to 15%
  • Anorectal Abscess & Fistula-in-Ano

Anorectal abscesses and fistulas represent two consecutive phases of the same disease process, unified by the cryptoglandular hypothesis .

Pathogenesis & The Cryptoglandular Hypothesis

There are 6 to 10 anal crypt glands situated circumferentially at the level of the dentate line in the crypts of Morgagni. Their ducts penetrate the internal anal sphincter into the intersphincteric space.

Obstruction of a crypt duct by inspissated stool, foreign material, or edema traps normal enteric bacterial flora ( Escherichia coli , Bacteroides fragilis , Enterococcus species, Streptococcus ), leading to acute glandular infection and purulent abscess formation.

Infection spreads along preformed tissue planes and pelvic spaces, producing distinct anatomical abscesses:

Perianal Abscess (60% of cases) : Most common. Infection extends downward superficial to the external sphincter into the subcutaneous perianal space.

Ischiorectal (Ischioanal) Abscess (20% of cases) : Infection penetrates through the external anal sphincter into the deep fat-filled ischioanal fossa. Presents with diffuse buttock induration and tenderness; fluctuance is often absent initially.

Intersphincteric Abscess (5% of cases) : Confined between the internal and external sphincter layers. Causes severe rectal pain and exquisite tenderness on DRE without external perianal swelling.

Supralevator Abscess (4% of cases) : Extends superiorly above the levator ani muscle into the pelvic peritoneum. Manifests as deep pelvic or lower abdominal pain, high fever, and leukocytosis without obvious perianal findings; requires pelvic CT or MRI for diagnosis.

Perianal Abscess: Clinical Hallmarks & Urgent Surgical Incision and Drainage

Presentation : Rapidly progressive, constant, severe, throbbing, dull perianal pain that worsens with sitting, coughing, or defecation. Accompanied by localized swelling, erythema, and low-grade fever.

Physical Examination : A warm, erythematous, exquisitely tender, indurated, and typically fluctuant mass located adjacent to the anal verge.

CRITICAL CLINICAL RULE : Prompt surgical incision and drainage (I&D) is the definitive, mandatory treatment for all anorectal abscesses . Treatment must NEVER be delayed for imaging or replaced by a trial of antibiotics alone! Antibiotics cannot penetrate an undrained purulent fluid cavity. Delaying surgical drainage leads to extensive tissue necrosis, sphincter destruction, and life-threatening necrotizing fasciitis ( Fournier gangrene ).

Role of Antibiotics : Routine uncomplicated perianal abscesses drained adequately do NOT require postoperative antibiotics. Antibiotics (oral amoxicillin-clavulanate or ciprofloxacin + metronidazole) are indicated ONLY as an adjunct to drainage in patients with:

  • Systemic toxicity or high fever (≥38.5°C);
  • Extensive surrounding cutaneous cellulitis;
  • Diabetes mellitus or chronic kidney disease;
  • Immunosuppression (HIV, neutropenia, post-transplant, active chemotherapy);

Valvular heart disease (endocarditis prophylaxis).

Fistula-in-Ano & Goodsall's Rule

Natural History : Following successful incision and drainage of an anorectal abscess, 30% to 50% of patients develop a persistent, chronic fistula-in-ano due to ongoing communication between the infected crypt gland (internal opening) and the drained cutaneous skin (external opening).

Presentation : Chronic, intermittent purulent, bloody, or serous drainage from a perianal skin opening, accompanied by perianal irritation, pruritus, and recurrent abscess flares.

Goodsall's Rule : Clinically predicts the internal trajectory of a fistula track based on the anatomical location of its external opening:

Anterior External Opening : If the external opening is situated anterior to an imaginary transverse line bisecting the anus, the fistula track travels in a straight, direct, radial path into the anal canal.

Posterior External Opening : If the external opening is situated posterior to the transverse line, the fistula track follows a curved, tortuous path that enters the anal canal in the posterior midline .

Exception : An anterior external opening located greater than 3 cm from the anal verge often follows a curved path entering the posterior midline (behaving like a posterior fistula). GOODSALL'S RULE

  • ANTERIOR VERGE
  • │
  • External │ External
  • Opening ─────── │ ─────── Opening
  • │ │ │
  • │ (Direct, │ (Direct, │
  • │ Radial) │ Radial) │
  • ▼ │ ▼
  • [Anal] ─────────┼───────── [Anal]
  • [Canal] │ [Canal]
  • ─────────────────────────────┼───────────────────────────── TRANSVERSE LINE
  • │
  • │
  • │ (Curved Track to
  • │ Posterior Midline)
  • │ ▲
  • │ ╱
  • [Posterior Midline] ◄─
  • │ ╲
  • │ External Opening
  • POSTERIOR VERGE
  • Pruritus Ani: Diagnostic Etiologies & Barrier Care

Pruritus ani is an intensely frustrating condition characterized by intractable perianal itching, frequently worse at night or after defecation.

Secondary Etiologies of Pruritus Ani

While 50% to 70% of cases are ultimately idiopathic, the clinician must systematically identify and treat secondary, reversible causes:

Infectious Causes :

Enterobius vermicularis (Pinworms) : Leading cause of perianal itching in pediatric patients and their family contacts. Gravid female worms migrate nocturnal to deposit eggs on perianal folds. Diagnosed via the morning cellophane tape test (visualizing oval eggs with one flattened side under light microscopy). Treatment: Oral albendazole (400 mg once, repeated in 2 weeks) or oral pyrantel pamoate; all household contacts must be treated simultaneously .

Candida albicans : Causes beefy red, glistening perianal erythema with distinct satellite pustules and papules . Common in patients with diabetes, immunosuppression, or recent broad-spectrum antibiotic use. Treated with topical clotrimazole or miconazole.

Scabies & STIs : Sarcoptes scabiei (nocturnal itching, finger web burrows), secondary syphilis (condyloma lata), HPV (condyloma acuminata), and HSV.

Dermatologic Conditions :

Allergic Contact Dermatitis : Commonly triggered by over-the-counter wipes containing preservatives (e.g., methylisothiazolinone ), perfumed soaps, synthetic hemorrhoidal ointments containing topical anesthetics (benzocaine, dibucaine), or neomycin.

Psoriasis (Inverse Psoriasis) : Well-demarcated, smooth, non-scaly, beefy pink plaques in the intertriginous perianal cleft.

Lichen Sclerosus : Hypopigmented, ivory-white, atrophic "cigarette paper" plaques in a figure-eight distribution around the vulva and anus, carrying an increased risk of squamous cell carcinoma.

Anorectal Structural Disorders :

Hemorrhoids (Grade II-IV), anal fissures, fistulas, and rectal mucosal prolapse cause chronic fecal soiling, mucus leakage, and moisture accumulation that macerates perianal skin.

Dietary Irritants :

Coffee (caffeinated and decaffeinated), tea, colas, chocolate, citrus fruits, tomatoes, beer, and spicy foods reduce resting anal sphincter pressure or cause irritating unabsorbed solutes in the stool.

Overzealous Hygiene ("The Itch-Scratch Cycle") :

The single most common aggravating factor. Patients erroneously attribute their itching to "poor hygiene" and vigorously scrub the perianal skin with harsh soaps, washcloths, and wet wipes. This strips the natural epidermal lipid barrier, inducing chronic microtrauma, neurogenic inflammation, and severe lichen simplex chronicus .

Evidence-Based Management Protocol

Eliminate All Cutaneous Irritants : Strictly discontinue all moist toilet wipes, scented soaps, perfumed toilet paper, witch hazel pads, and over-the-counter hemorrhoid creams containing local anesthetics.

Gentle Water-Only Hygiene : Cleanse the perianal area after defecation using plain lukewarm water only (via a handheld bidet, perineal squeeze bottle, or gentle shower). Never scrub or use soap on the perianal verge.

Keep the Anoderm Completely Dry : Gently pat the area dry with a clean, soft cotton towel without rubbing, or dry the area thoroughly using an electric hairdryer set on the cool air setting .

Short-Course Topical Corticosteroid : Apply a thin layer of mild 1% hydrocortisone ointment twice daily for no longer than 7 to 14 days to break the acute neurogenic inflammatory itch cycle. Topical corticosteroids must never be used long term because they induce severe perianal skin atrophy, striae, secondary fungal superinfection, and rebound pruritus.

Protective Barrier Ointments : Following hygiene care, apply a generous protective layer of zinc oxide ointment or white petrolatum (Vaseline) to shield vulnerable perianal skin from moisture, enzymatic fecal bile salts, and fecal acid contact.

Loading diagram... Diagnostic and Management Pathways for Anorectal Conditions